Baht 5.79 million 11.25 2. The operation results (from the consolidated finance statements) Item Third quarter of 2019 Third quarter of 2018 Profit (Loss) for three months attributable to equity holders

% 100.0% Net profit - Equity holders of the Company 122.36 14.7% 145.42 17.5% 142.28 17.4% -2.2% 16.3% 542.89 17.5% 583.10 17.5% 7.4% Y.2018 %YoY%YoY Y.2017 Income Statement Q4/2017 Q3/2018 Q4/2018 %QoQ

attributable to Equity holders of the Company in Q3/2019 and of the nine months of 2019 were of Bt255. 7 million and Bt779.7 million which decreased by Bt48.9 million or 16.1%(y-o-y) and decreased by Bt89.8

- Equity holders of the Company 142.28 17.4% 143.78 18.4% 145.69 19.1% 1.3% 2.4% 583.10 17.5% 584.23 18.6% 0.2% Y.2018 Y.2019 %YoY%YoYStatement of Comprehensive Income Q4/2018 Q3/2019 Q4/2019 %QoQ 3 Forth

Warrant holders as follows. New Exercise Ratio 1 unit of warrant exercised to purchase 1.185 ordinary share New Exercise Price 4.221 Baht per share.  On 23 April 2019, the Annual General Meeting of the

33.8% Current liabilities 1,695 53.2% 2,492 58.5% 797 47.0% Non-current liabilities 307 9.6% 434 10.2% 127 41.4% Total liabilities 2,002 62.9% 2,926 68.7% 924 46.2% Total shareholders’ equity 1,183 37.1

growth rate of total expenses at 20.3%(y-o-y), then the Net profit attributable to Equity holders of the Company in Q2/2019 and of the first six months of 2019 were of Bt176.1 million and Bt524.0 million

% -3.9% Non-controlling interests of the subsidiaries 0.42 0.1% (0.40) -0.1% (0.35) 0.0% 100.0% 100.0% Net profit - Equity holders of the Company 150.40 17.7% 149.51 18.7% 145.25 18.1% -2.9% -3.4

franchise rights holders (franchisor) are not able to deliver the products (medicines, supplies and equipment) as they will affect the sales and services that are not in line with the target. And the cost of

 The Board of Directors meeting held on 7 August 2019 approved the payment of the interim dividend for the first half of the Company’s performance to shareholders for a total of THB 52mn, at a rate of